Search results
Results From The WOW.Com Content Network
PFE Revenue (TTM) data by YCharts Pfizer's vaccine (Comirnaty) and treatment option (Paxlovid) combined for $56 billion in revenue in 2022. Those two products represented just $2.4 billion of ...
PFE Chart. PFE data by YCharts. ... the S&P 500 trades above its historical norms, leading some to speculate about potential market downturns. I'd say the odds are that Pfizer stock will ...
Pfizer (NYSE: PFE) stock investors are curious about the valuation and prospects for the healthcare company. Stock prices used were the afternoon prices of Jan. 1, 2025. The video was published on ...
Pfizer was founded in 1849 as "Charles Pfizer & Company" by Charles Pfizer and Charles F. Erhart, [5] two cousins who had immigrated to the United States from Ludwigsburg, Germany. The business produced chemical compounds, and was headquartered on Bartlett Street [ 6 ] in Williamsburgh, New York where they produced an antiparasitic called ...
PFE data by YCharts. 1. Pfizer. Although Pfizer hasn't performed well recently, it's important to point out that if the company hadn't made several important moves in recent years, its business ...
The drugmaker has shed nearly $180 billion in market cap after struggling to chart a new course as the COVID-19 pandemic waned. ... Pfizer’s stock hit an all-time high of $61.25 in December 2021 ...
One stock that just can't seem to catch a break of late is Pfizer (NYSE: PFE). Given how well Pfizer has performed in recent years due to its COVID-19 vaccine and pill (its revenue topped $100 ...
The story of Pfizer's stock over the last few years is inseparable from the trajectory of its coronavirus vaccine, Comirnaty. In 2022, the vaccine contributed to a total of more than $100 billion ...